Assignee
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD
GB·13 granted patents·7 pending applications·41 citations·filing 2014–2017
Top patents by PatentIndex Score
20 records- 0188US9505745B2Enhancer of zeste homolog 2 inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2014·Granted Nov 29, 2016·11 cites·20 claims
- 0285US9556157B2Enhancer of zeste homolog 2 inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2014·Granted Jan 31, 2017·8 cites·20 claims
- 0385US9533948B2Chemical compoundsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2014·Granted Jan 3, 2017·5 cites·6 claims
- 0483US9540400B2Compounds as diacylglycerol acyltransferase inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2016·Granted Jan 10, 2017·4 cites·16 claims
- 0578US9790212B2Enhancer of zeste homolog 2 inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2016·Granted Oct 17, 2017·2 cites·20 claims
- 0674US9809540B2Hydrobromide salt of N-(4-chloro-2-hydroxy-3-((3S)-3-piperidinylsulfonyl)phenyl-N'-(3-fluoro-2-methylphenyl)ureaGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2014·Granted Nov 7, 2017·3 cites·6 claims
- 0774US9795597B2Cyclopropylamines as LSD1 inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2016·Granted Oct 24, 2017·1 cites·6 claims
- 0872US9670221B2Furopyridines as bromodomain inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2014·Granted Jun 6, 2017·3 cites·13 claims
- 0970US9446041B2Method of treatmentGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2015·Granted Sep 20, 2016·2 cites·6 claims
- 1066US9834529B2Synthesis of benzothiazepinesGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2015·Granted Dec 5, 2017·1 cites·10 claims
- 1163US9840496B2CD38 inhibitors and methods of treatmentGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2015·Granted Dec 12, 2017·1 cites·6 claims
- 1261US2016251380A1Tricyclic benzoxaborole compounds and uses thereofGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2014·Application pending·0 cites
- 1357US9725437B2Fatty acid synthase inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2016·Granted Aug 8, 2017·0 cites·10 claims
- 1446US2017285024A1Compliment factor i bioassayGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2017·Application pending·0 cites
- 1543US9707219B2Losmapimod for use in treating glomerular diseaseGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2014·Granted Jul 18, 2017·0 cites·6 claims
- 1641US2017333460A1Long acting pharmaceutical compositions for hepatitis cGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2015·Application pending·0 cites
- 1738US2017100385A1Pharmaceutical compositions comprising danirixin for treating infectious diseasesGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2015·Application pending·0 cites
- 1837US2017334891A1Enhancer of zeste homolog 2 inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2015·Application pending·0 cites
- 1933US2017015666A1Enhancer of zeste homolog 2 inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2015·Application pending·0 cites
- 2022US2016361309A1Methods of treating cancer patients responding to ezh2 inhibitor gsk126GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →